Published in Hepatitis Weekly, November 26th, 2007
Genelabs had cash and cash equivalents of $20.2 million at September 30, 2007. Subsequent to September 30, 2007 our cash and cash equivalents balance...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.